Imakethi yempompo ye-insulin ukuya kwi-13.38 yeebhiliyoni zeedola, kwihlabathi liphela, ngo-2030 kwi-13.6% CAGR

 Imarike yehlabathi ye Impompo ye-insulin bekunjalo ixabisa i-USD 3.9 yebhiliyoni ngo-2020. Kulindeleke ukuba ukufikelela kwi-USD 13.38 yebhiliyoni ngo-2030. lo I-CAGR iya kuba yi-13.6% phakathi kuka-2021 no-2030.

Impompo ye-insulin zizixhobo ezincinci, ezilawulwa yikhompyuter ezinikezela ngeedosi ze-insulin kwizigulana ezinesifo seswekile. Impompo ye-insulin yamkelwe ngokubanzi ngokusebenza kwayo ekulawuleni nasekulawuleni isifo seswekile. Bahambisa iidosi ze-insulin rhoqo kwaye ngexesha. Isifo seswekile sesona sizathu sokunyuka kwemfuno yempompo ye-insulin. Ngokutsho kwedatha ye-International Diabetes Federation, i-552 yezigidi zabantu emhlabeni jikelele kulindeleke ukuba babe nesifo seswekile ngo-2030. Iimeko zesifo seswekile ziyanda ngenxa yokutshintsha kwendlela yokuphila yabathengi, ukutshintsha kwendlela yokutya, kunye nemikhwa engalunganga yokutya.

Isicelo seSampuli yeKopi yempompo ye-insulin yeMarike ene-TOC eGqibeleleyo kunye neMizobo kunye neeGrafu@ https://market.us/report/insulin-pump-market/request-sample

IMakethi yempompo ye-insulin: Abaqhubi

Ukuchasana nokukhula kwemarike, ukunyuka kwesifo seswekile phakathi kwabemi ngokubanzi Ukunyuka kokuxhaphaka kwesifo seswekile kunokubalelwa kwizinto ezininzi, kubandakanya ukutyeba kakhulu kunye nendlela yokuphila yokuhlala.

Ngokutsho kwe-IDF Diabetes Atlas, i-537 yezigidi zabantu abaneminyaka eyi-20-79 baya kuba nesifo sikashukela ngo-2021. Inani elipheleleyo lezigulane zesifo sikashukela kulindeleke ukuba linyuke ukuya kwi-643 yezigidi nge-2030 kunye ne-783 yezigidi kwi-2045.

Njengoko sikhula, umngcipheko wokuba nesifo seswekile uyenyuka. Ngenxa yoko, kukho ukwanda kwenani labantu abangaphezu kweminyaka engama-65 abasemngciphekweni wokuba nesifo seswekile, iglaucoma, noxinzelelo lwegazi.

Ngokutsho kwe-Endocrine Society (uMbutho woPhando lweSishukela), kuqikelelwa ukuba i-33.0% yabantu abadala abaneminyaka eyi-65 nangaphezulu baya kuba nesifo seswekile ngo-2022.

Inani elikhulu le-type1 yeswekile kwihlabathi liphela lifuna i-insulin ukulawula isifo sabo. Ukukhula kweMarike yePump ye-insulin kulindeleke ukuba kuqhutywe kukunyuka kolwazi lwale mpompo phakathi kwesifo seswekile kunye nezibonelelo ezinxulumene nolawulo lwezifo.

Ukuvunywa kweMveliso yakutsha nje kunye nobukho boMbhobho oQhubekileyo wokuKhawulezisa ukuKhula kweMarike

Abadlali bemarike bagxile kwiinzame zabo kwi-R&D kunye nokuqaliswa kweemveliso ezintsha. Izilingo zeklinikhi ziye zaxhasa i-R & D ngokubonisa ukuphuculwa okuqhubekayo kulawulo lwe-glucose kwi-type2 yezigulane zesifo sikashukela ezifumana unyango lwempompo xa kuthelekiswa nezigulane ezifumana unyango lwe-Multiple Daily Injection (MDI).

Impompo ye-insulin Imarike: Izithintelo

Impompo ye-insulin enezinga eliphezulu lokwamkelwa

Ezi mpompo zikhulile ngenxa yokunyuka kokuxhaphaka kwe-type1 kunye ne-type2 yeswekile kwihlabathi jikelele kunye nemfuno ekhulayo yempompo ekulula ukuyisebenzisa kune-MDI. Ukukhula kwemarike kulindeleke ukuba kuthintelwe lixabiso eliphezulu lonyango lwempompo ye-insulin. Impompo, izixhobo zale mihla zokuhanjiswa kweziyobisi ezihambisa amachiza, ziguqule ukhathalelo lwempilo kwaye zazisa ixesha elitsha kushishino lwezempilo.

Ngokwenqaku likaMdedge, unyango lwempompo lubiza kakhulu kunenaliti ye-insulin yemihla ngemihla kwizigulana ezinesifo seswekile. Lo mahluko ufikelela malunga nama-30%.

Ezi mpompo zineendleko ezongezelelweyo zezinto ezisetyenziswayo ezifana neebhetri, izinzwa, kunye nezinye izinto ezisetyenziswayo. Ixabiso eliphakathi lase-US lale mpompo yi-USD 3,839.6 (ixabiso le-OEM). Iindleko zonyaka zokusetyenziswa yi-USD 1,067.0 (ixabiso le-OEM). Amaxabiso anokwahluka ngokuxhomekeka kwi-brand kunye nobukhulu bempompo.

Le mpompo ayisetyenziswanga ngokubanzi kumazwe asakhasayo ngenxa yokungabikho kolwazi malunga neendlela zonyango lwesifo sikashukela kunye nemigaqo-nkqubo yokubuyisela imbuyekezo.

Ixabiso eliphezulu lempompo ye-insulin lithintela ukwamkelwa kwabo kwimarike. Ezi mpompo zikwabiza kakhulu kuneendleko kwaye kukho imbuyekezo encinci kumazwe asakhasayo. Oku kukhokelele kumlinganiselo ophantsi wokwamkelwa kwezi mveliso kurhwebo lwehlabathi.

Ngaba ukhona umbuzo?
Buza Apha Ukwenziwa KweNgxelo: https://market.us/report/insulin-pump-market/#inquiry

Impompo ye-insulin IiNdlela eziPhambili kwiMarike:

Isifo seswekile sesona sizathu siphambili sokufa kwihlabathi liphela. Ikwangumngcipheko kwezinye iingxaki zempilo. Ukukhula kwemarike kukwaqhutywa linani elandayo lohlobo 1 lweswekile. Imarike ikwaqhutywa kukwandisa ulwazi malunga nohlobo loku-1 lweswekile kunye nendlela yokuphila yokuhlala.

I-IDF Atlas (i-International Diabetes Foundation) ithi isifo seswekile siya kubangela ukufa kwabantu abamalunga ne-6.7 yezigidi ngo-2021. Ngokutsho kwe-IDF Atlas, inani lezigulane zesifo sikashukela kulindeleke ukuba linyuke nge-51% ngo-2045.

Ukukhula kwemarike kukwaqhutywa ngamanyathelo karhulumente okwazisa malunga nemigaqo-nkqubo yokhathalelo lwempilo kwihlabathi liphela kunye nokulawula isifo seswekile. Kubekho ukonyuka kwenkcitho yokhathalelo lwempilo kunye nemfuno yempompo ye-insulin engcono. Ezi mpompo ze-insulin zisebenziseka kalula kwaye azibonakali. Oku kuya kuqhuba ukukhula kweemarike kwixesha eliqikelelwayo.

Uphuhliso lwakutsha nje:

I-Insulet Corporation ibhengeze i-USD 200 yezigidi zotyalo-mali kwindawo yayo yokuvelisa iJohor kwiminyaka emihlanu ngoJuni 2, 2022. I-Insulet Corporation yinkokeli yehlabathi kwi-tubeless insulin pump technology kunye nezixhobo. Njengenxalenye yenjongo yayo yokwandisa amandla ayo okwenza umhlaba, inkampani iya kuba nakho ukuvelisa i-Omnipod Insulin Management System.

I-Ypsomed kunye neCamDiab ibhengeze intsebenziswano ngo-Ephreli 2022 ukwenza inkqubo ye-AID edibeneyo (ukuhanjiswa kwe-insulin ngokuzenzekelayo). Inkqubo ye-AID edibeneyo iya kudibanisa i-Abbott's FreeStyle Libre3 kunye ne-Ypsomed's MyLife YpsoPump, evumela indlela ehlakaniphile kunye nezenzekelayo yokuhambisa i-insulin usebenzisa idatha ye-glucose yokwenene.

Isivumelwano sabhengezwa kwiiSeshini zeNzululwazi ze-American Diabetes Association ngomhla wesi-3 kuJuni ngo-2022 nguDiabeloop, inkokeli yehlabathi kwi-AI yonyango kunye ne-SOOIL, inkampani ekhokelayo kunyango oluphezulu lweswekile. Le ntsebenziswano iya kubavumela ukuba baqhube iimvavanyo zeklinikhi ukwandisa intsebenziswano yabo kunye nokubonelela ngokufikelela kwiimveliso zabo kwizigulane ezininzi ngokusebenzisa iimveliso ezintsha.

Ubume beNgxelo

iimpawuiinkcukacha
Ubungakanani beMarike ngo-2020USD 3.9 yezigidi zezigidi
Inqanaba lokukhulaI-CAGR ye-13.6%
Imbali2016-2020
Isiseko unyaka2021
IiYunithi zobungakananiUSD KwiBn
Inani laMaphepha kwiNgxeloAmaphepha angama-200+
Inani leeTheyibhile & Amanani150 +
formatPDF/Excel
Umyalelo ngokuthe ngqo kule NgxeloIyafumaneka- Ukuthenga Le Ngxelo yeNtlawulo Cofa Apha

Abadlali abaPhambili kwiMarike:

  • Medtronic
  • UJohnson kunye noJohnson
  • Roche
  • SOOIL
  • Tandem ukhathalelo lwesifo seswekile
  • Inkampani yeInsulet
  • Valeritas
  • Microport

uhlobo

  • Ukuhlamba
  • Indawo yokugcina
  • Ukumisela Iseti

isicelo

  • Chwetheza isifo seswekile
  • Uhlobo lwesibini lweswekile

Ishishini, ngokweNgingqi

  • IAsia-Pasifiki [eTshayina, eMzantsi-mpuma Asia, eIndiya, eJapan, eKorea, eNtshona Asia]
  • IYurophu [eJamani, e-UK, eFransi, eItali, eRashiya, eSpeyin, eNetherlands, eTurkey, eSwitzerland]
  • UMntla Melika [eUnited States, eKhanada, eMexico]
  • kuMbindi Mpuma neAfrika [GCC, kuMntla Afrika, eMzantsi Afrika]
  • UMzantsi Melika [iBrazil, iArgentina, iColumbia, iChile, iPeru]

Imibuzo ephambili:

  • Ngabaphi abadlali abakhulu kwimakethi yempompo ye-insulin?
  • Yintoni i-CAGR yentengiso yempompo ye-insulin ngo-2019?
  • Zeziphi izinto eziphambili zokuqhuba kwimakethi yempompo ye-insulin?
  • Leliphi icandelo elikhula ngokukhawuleza kwimakethi yempompo ye-insulin?
  • Ngowuphi ummandla oza kulawula imakethi yempompo ye-insulin yehlabathi?
  • Lithini ixabiso lekamva lemarike yempompo ye-insulin?
  • Leliphi icandelo elinesona sabelo sikhulu semarike sempompo ye-insulin?

Ezinye iiNgxelo eziNxulumeneyo kwiNdawo yethu yeMarket.us:

IMarike yeZixhobo zokuZisa i-insulin ezizenzekelayo kuqikelelwa ukufikelela kuqingqo-maxabiso USD 28.87 zigidi ngo-2032 kwi-CAGR ye 7.9%, ukusuka iUSD 12.51 billion kwi 2021.

IMarike yeNkqubo yokuhanjiswa kwe-insulin yeHlabathi kuqikelelwa ukuba ifikelele kwixabiso elingaphezulu kwe-USD 11.42 yeBhiliyoni ngo-2017 kwi-CAGR engaphezulu kwe-7.0% kwixesha loqikelelo.

IMarike yeSixhobo soNyango lwehlabathi jikelele kuqikelelwa ukuba USD 347.6 Mn ngo-2022 ukufikelela USD 600.0 Mn ngo-2032 e CAGR of 6.9%.

Imakethi yehlabathi yezinto ezinxitywayo zokulawulwa kokuzalwa kuqikelelwa ukufikelela kuqingqo-maxabiso I-USD 63.36 Bn ngo-2032 e CAGR of 13.2%, ukusuka I-USD 18.34 Bn kwi 2022.

IMakethi eZinxitywayo zeswekile kuqikelelwa ukufikelela kuqingqo-maxabiso I-USD 36.25 Bn ngo-2032 kwi-CAGR ye 6.3%, ukusuka iUSD 20.92 Bn kwi 2021

Ukhathalelo lwempilo lwehlabathi kwi-Intanethi yeZinto (IoT) imakethi yokhuseleko kuqikelelwa ukufikelela kuqingqo-maxabiso I-USD 36.27 Bn ngo-2032 e CAGR of 36%, ukusuka I-USD 1.68 Bn kwi 2022.

imarike yezixhobo ze-pancreas eyenziweyo kwihlabathi ibifanele USD 208.1 yezigidi ngo-2021. Kulindeleke ukuba ikhule kwi-CAGR ye 19.1% phakathi kwe-2023 ukuya kwi-2032.

Imarike yezempilo yehlabathi jikelele ibifanele USD 311.54 yezigidi zezigidi ngo-2021. Eli nani liya kwanda ngo- I-CAGR ye-8.4% phakathi kowe-2023-2032

Malunga neMarket.us

I-Market.US (Inikwe amandla nguPrudour Private Limited) igxile kuphando olunzulu lwemarike kunye nohlalutyo kwaye iye yabonisa amandla ayo njengenkampani yokubonisana kunye neyokwenza uphando lwemalike, ngaphandle kokuba yingxelo efunwa kakhulu emva kophando lwemarike enikezela ngokuqinileyo.

Iinkcukacha zoqhakamshelo:

IQela loPhuhliso loShishino lweHlabathi – Market.us

Idilesi: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States

Ifowuni: +1 718 618 4351 (yamazwe ngamazwe), Ifowuni: +91 78878 22626 (Asia)

email: [imeyile ikhuselwe]

INTO ONOKUYITHATHA KWELI NQAKU:

  • These pump have grown due to the rising prevalence of type1 and type2 diabetes worldwide and the growing demand for pump that are easier to use than the MDI.
  • The high price of an insulin pump is restricting their adoption in the market.
  •  As a result, there is an increase in the number of people over 65 who are at risk for developing diabetes, glaucoma, and hypertension.

<

Malunga nombhali

Linda Hohnholz

Umhleli oyintloko we eTurboNews esekwe kwi-eTN HQ.

Bhlisa
Yaziswe ngawo
guest
0 izimvo
Inline feedbacks
Jonga zonke izimvo
0
Ndingazithanda iingcinga zakho, nceda uphawule.x
Yabelana ku...